Larson Financial Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $4.11M | Buy |
47,643
+5,096
| +12% | +$449K | 0.1% | 168 |
|
|
2026
Q2 | $3.33M | Sell |
42,547
-527
| -1% | -$42.5K | 0.09% | 187 |
|
|
2026
Q1 | $3.73M | Buy |
43,074
+3,357
| +8% | +$322K | 0.12% | 151 |
|
|
2025
Q4 | $3.82M | Buy |
39,717
+123
| +0.3% | +$11.9K | 0.13% | 148 |
|
|
2025
Q3 | $3.77M | Buy |
39,594
+1,559
| +4% | +$143K | 0.13% | 143 |
|
|
2025
Q2 | $3.32M | Buy |
38,035
+3,453
| +10% | +$293K | 0.13% | 149 |
|
|
2025
Q1 | $3.11M | Buy |
34,582
+4,947
| +17% | +$443K | 0.15% | 130 |
|
|
2024
Q4 | $2.37M | Buy |
29,635
+4,960
| +20% | +$429K | 0.12% | 146 |
|
|
2024
Q3 | $2.22M | Buy |
24,675
+3,903
| +19% | +$328K | 0.13% | 148 |
|
|
2024
Q2 | $1.63M | Buy |
20,772
+2,258
| +12% | +$185K | 0.11% | 153 |
|
|
2024
Q1 | $1.61M | Buy |
18,514
+274
| +2% | +$23.4K | 0.12% | 142 |
|
|
2023
Q4 | $1.5M | Sell |
18,240
-2,716
| -13% | -$207K | 0.13% | 139 |
|
|
2023
Q3 | $1.64M | Sell |
20,956
-2,009
| -9% | -$168K | 0.16% | 121 |
|
|
2023
Q2 | $2.02M | Buy |
22,965
+980
| +4% | +$84.4K | 0.2% | 94 |
|
|
2023
Q1 | $1.77M | Sell |
21,985
-114
| -0.5% | -$9.29K | 0.19% | 105 |
|
|
2022
Q4 | $1.72M | Sell |
22,099
-312
| -1% | -$25.3K | 0.21% | 97 |
|
|
2022
Q3 | $1.81M | Buy |
22,411
+19,655
| +713% | +$1.77M | 0.26% | 62 |
|
|
2022
Q2 | $247K | Sell |
2,756
-1,898
| -41% | -$192K | 0.04% | 165 |
|
|
2022
Q1 | $516K | Sell |
4,654
-386
| -8% | -$40.8K | 0.08% | 105 |
|
|
2021
Q4 | $521K | Buy |
5,040
+4,626
| +1,117% | +$536K | 0.08% | 108 |
|
|
2021
Q3 | $52K | Buy |
414
+121
| +41% | +$15.7K | 0.01% | 293 |
|
|
2021
Q2 | $36K | Sell |
293
-62
| -17% | -$7.78K | 0.01% | 333 |
|
|
2021
Q1 | $42K | Buy |
355
+1
| +0.3% | +$117 | 0.01% | 286 |
|
|
2020
Q4 | $41K | Buy |
354
+276
| +354% | +$30.4K | 0.01% | 247 |
|
|
2020
Q3 | $8K | Hold |
78
| – | – | ﹤0.01% | 471 |
|
|
2020
Q2 | $7K | Buy |
+78
| New | +$7.48K | ﹤0.01% | 439 |
|
|
2020
Q1 | – | Sell |
-76
| Closed | -$9K | – | 611 |
|
|
2019
Q4 | $9K | Buy |
76
+26
| +52% | +$2.85K | 0.01% | 310 |
|
|
2019
Q3 | $5K | Buy |
+50
| New | +$5.22K | ﹤0.01% | 367 |
|
|
2019
Q2 | – | Sell |
-162
| Closed | -$15K | – | 539 |
|
|
2019
Q1 | $15K | Buy |
+162
| New | +$14.5K | 0.01% | 200 |
|
Other funds holding MDT
Larson Financial Group's MDT Position: Q3 2026 in Review
Larson Financial Group increased its Medtronic (MDT) stake by 12% in Q3 2026, buying an estimated $449K and bringing the position to 47,643 shares worth $4.11M. The position accounts for 0.1% of the portfolio, ranked #168.
Larson Financial Group first reported a position in MDT in Q1 2019 and has held it in 29 quarters since. 1,278 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Larson Financial Group held 47,643 shares of Medtronic worth $4.11M as of Q3 2026.
- Larson Financial Group bought 5,096 Medtronic shares in Q3 2026, an estimated $449K.
- Medtronic made up 0.1% of Larson Financial Group's portfolio in Q3 2026, its #168 holding.
- Larson Financial Group first reported a position in Medtronic in Q1 2019 and has held it in 29 quarters since.
- 1,278 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.